These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23624842)

  • 21. A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells/.
    Downes CS; Clarke DJ; Mullinger AM; Giménez-Abián JF; Creighton AM; Johnson RT
    Nature; 1994 Dec; 372(6505):467-70. PubMed ID: 7984241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. cin-4, a gene with homology to topoisomerase II, is required for centromere resolution by cohesin removal from sister kinetochores during mitosis.
    Stanvitch G; Moore LL
    Genetics; 2008 Jan; 178(1):83-97. PubMed ID: 18202360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel indication for cancer therapy: Chk1 inhibition sensitizes tumor cells to antimitotics.
    Xiao Z; Xue J; Semizarov D; Sowin TJ; Rosenberg SH; Zhang H
    Int J Cancer; 2005 Jul; 115(4):528-38. PubMed ID: 15688426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The mitotic spindle checkpoint is a critical determinant for topoisomerase-based chemotherapy.
    Vogel C; Kienitz A; Müller R; Bastians H
    J Biol Chem; 2005 Feb; 280(6):4025-8. PubMed ID: 15611124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of checkpoint kinase 1 following gemcitabine-mediated S phase arrest results in CDC7- and CDK2-dependent replication catastrophe.
    Warren NJH; Eastman A
    J Biol Chem; 2019 Feb; 294(6):1763-1778. PubMed ID: 30573684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of kinetochore fragments during mitosis with unreplicated genomes.
    Johnson MK; Wise DA
    Cytoskeleton (Hoboken); 2010 Mar; 67(3):172-7. PubMed ID: 20175217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ERK1/2 signaling plays an important role in topoisomerase II poison-induced G2/M checkpoint activation.
    Kolb RH; Greer PM; Cao PT; Cowan KH; Yan Y
    PLoS One; 2012; 7(11):e50281. PubMed ID: 23166842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dovitinib induces mitotic defects and activates the G2 DNA damage checkpoint.
    Man WY; Mak JP; Poon RY
    J Cell Mol Med; 2014 Jan; 18(1):143-55. PubMed ID: 24238094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell cycle responses to Topoisomerase II inhibition: Molecular mechanisms and clinical implications.
    Soliman TN; Keifenheim D; Parker PJ; Clarke DJ
    J Cell Biol; 2023 Dec; 222(12):. PubMed ID: 37955972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cells.
    Parsels LA; Morgan MA; Tanska DM; Parsels JD; Palmer BD; Booth RJ; Denny WA; Canman CE; Kraker AJ; Lawrence TS; Maybaum J
    Mol Cancer Ther; 2009 Jan; 8(1):45-54. PubMed ID: 19139112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutting edge: Chk1 directs senescence and mitotic catastrophe in recovery from G₂ checkpoint arrest.
    Poehlmann A; Habold C; Walluscheck D; Reissig K; Bajbouj K; Ullrich O; Hartig R; Gali-Muhtasib H; Diestel A; Roessner A; Schneider-Stock R
    J Cell Mol Med; 2011 Jul; 15(7):1528-41. PubMed ID: 20716119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human topoisomerase II function, tyrosine phosphorylation and cell cycle checkpoints.
    Kaufmann WK
    Proc Soc Exp Biol Med; 1998 Mar; 217(3):327-34. PubMed ID: 9492343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitotic checkpoints, MUGs and kinetochores.
    Brinkley BR
    Cell Cycle; 2013 Jun; 12(12):1822-3. PubMed ID: 23759568
    [No Abstract]   [Full Text] [Related]  

  • 34. ATR enforces the topoisomerase II-dependent G2 checkpoint through inhibition of Plk1 kinase.
    Deming PB; Flores KG; Downes CS; Paules RS; Kaufmann WK
    J Biol Chem; 2002 Sep; 277(39):36832-8. PubMed ID: 12147700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PICH, a centromere-associated SNF2 family ATPase, is regulated by Plk1 and required for the spindle checkpoint.
    Baumann C; Körner R; Hofmann K; Nigg EA
    Cell; 2007 Jan; 128(1):101-14. PubMed ID: 17218258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway.
    Mikhailov A; Shinohara M; Rieder CL
    J Cell Biol; 2004 Aug; 166(4):517-26. PubMed ID: 15302851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of checkpoint kinase 1 in preventing premature mitosis in response to gemcitabine.
    Morgan MA; Parsels LA; Parsels JD; Mesiwala AK; Maybaum J; Lawrence TS
    Cancer Res; 2005 Aug; 65(15):6835-42. PubMed ID: 16061666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitosis in cells with unreplicated genomes (MUGs): spindle assembly and behavior of centromere fragments.
    Wise DA; Brinkley BR
    Cell Motil Cytoskeleton; 1997; 36(3):291-302. PubMed ID: 9067624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topoisomerase II SUMOylation activates a metaphase checkpoint via Haspin and Aurora B kinases.
    Pandey N; Keifenheim D; Yoshida MM; Hassebroek VA; Soroka C; Azuma Y; Clarke DJ
    J Cell Biol; 2020 Jan; 219(1):. PubMed ID: 31712254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship of premature mitosis to cytotoxicity in response to checkpoint abrogation and antimetabolite treatment.
    Morgan MA; Parsels LA; Parsels JD; Lawrence TS; Maybaum J
    Cell Cycle; 2006 Sep; 5(17):1983-8. PubMed ID: 16931916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.